Rallybio Corporation (RLYB) Analyst Estimates Annual - Discounting Cash Flows
RLYB
Rallybio Corporation
RLYB (NASDAQ)
Period Ending: 2029
12-31
2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
Number of Analysts 1 1 1 3 3 2
Estimated Revenue
Low 89 87.5 87.9 0.08 0.6 0.674
Average 89 87.5 87.9 0.08 0.733 0.674
High 89 87.5 87.9 0.08 0.8 0.674
Estimated EBITDA
Low 53.4 52.5 52.74 0.048 0.36 0.404
Average 53.4 52.5 52.74 0.048 0.44 0.404
High 53.4 52.5 52.74 0.048 0.48 0.404
Estimated EBIT
Low 53.4 52.5 52.74 0.048 0.36 0.404
Average 53.4 52.5 52.74 0.048 0.44 0.404
High 53.4 52.5 52.74 0.048 0.48 0.404
Estimated Net Income
Low 21.34 -16.98 -62.7 -42.46 -23.73 -62.76
Average 21.34 -16.98 -62.7 -42.46 -23.73 -61.83
High 21.34 -16.98 -62.7 -42.46 -23.73 -60.91
Estimated SGA Expenses
Low 620.5 610 612.8 0.558 4.18 4.7
Average 620.5 610 612.8 0.558 5.11 4.7
High 620.5 610 612.8 0.558 5.58 4.7
Estimated EPS
Low 3.92 -3.12 -11.52 -7.8 -4.36 -11.53
Average 3.92 -3.12 -11.52 -7.8 -4.36 -11.36
High 3.92 -3.12 -11.52 -7.8 -4.36 -11.19
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program